News & Media

Purdue is at the forefront of medical advances and provides timely news updates about its family of products, resources, and events.

PrintFont Size

News Archives

Welcome to the Purdue News Archives

In this section you will find historical news and events pertaining to Purdue Pharma L.P. and its family of products.

2011

Common Errors in the Media about OxyContin® (Oxycodone HCl Controlled-Release) Tablets CII

12/6/2011

NEA Health Information Network and Purdue Pharma L.P. Partner to Help Kids be Safe

10/31/2011

Butrans® (Buprenorphine) Transdermal System CIII Pivotal Phase 3 Data Published In The Journal Of Pain And Symptom Management

10/26/2011

NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to support State Prescription Drug Monitoring Programs

10/18/2011

7th Heaven and “Game Time” Star Catherine Hicks to Appear at the National Community Pharmacists Association’s Convention October 10, 2011 in Nashville for Education Effort to Help Prevent Prescription Medication Abuse

10/10/2011

Purdue Pharma L.P. and the National Community Pharmacists Association Join Forces to Help Prevent Pharmacy Robbery

10/10/2011

Actress Jennifer Grey Spearheads National Initiative To Promote Effective Communication Between People Living With Pain And Healthcare Professionals

9/27/2011

In The Face of Pain® Offers New Tools and Resources to Patients, Caregivers and Healthcare Professionals Advocating for Better Pain Care

9/22/2011

Results Of A Pivotal Phase 3 Efficacy And Safety Study For Butrans® (Buprenorphine) Transdermal System Ciii Published In The Journal Of Pain

9/19/2011

New Photo Contest Gives People with Chronic Pain a Chance to Share Their Experience

8/1/2011

New Online Resource to Help Combat Abuse of Prescription Medications Launched By Purdue Pharma L.P.

7/25/2011

Purdue Pharma L.P. Aids Communities Damaged by Tornadoes in North Carolina

5/2/2011

New Educational Resources Help Healthcare Professionals Recognize, Address Substance Abuse in Clinical Practice Settings

4/19/2011

Purdue Pharma L.P. Offers $1 Million to Help Fund Florida’s Prescription Drug Monitoring Program

3/9/2011

BUTRANS™ (buprenorphine) TRANSDERMAL SYSTEM CIII NOW AVAILABLE

1/20/2011

2010

Purdue Pharma L.P. Honored for Youth Prevention Efforts

10/26/2010

Purdue Pharma L.P. Honored for Youth Prevention Efforts

10/26/2010

Purdue Pharma L.P. and the National Community Pharmacists Association Join Forces to Help Prevent Pharmacy Burglary

10/25/2010

“7th Heaven” Star Catherine Hicks Teams with Purdue Pharma L.P. and the National Community Pharmacists Association to Help Prevent Prescription Medication Abuse

10/19/2010

NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to support State Prescription Drug Monitoring Programs

10/19/2010

In the Face of Pain® Launches New Resource Guide for People with Pain and Advocates

10/5/2010

Twitter Provides New Way to Fight Pharmacy Crime RxPATROL® Launches Twitter Page

9/21/2010

Statement of Purdue Pharma L.P. Regarding OxyContin® (oxycodone HCl controlled-release) Tablets Risk Evaluation and Mitigation Strategy

7/29/2010

In the Face of Pain® Launches New Facebook Community for Pain Management Advocates;

7/14/2010

Purdue Pharma L.P. Provides Free Security Mobiles and Educational Safety Videos to Good Neighbor Pharmacy Members

7/12/2010

Purdue Pharma L.P. Receives FDA Approval for Butrans™ (buprenorphine) Transdermal System CIII

7/1/2010

In the Face of Pain® Offers Social Media 101 for Pain Management Advocates

6/2/2010

Statement of Purdue Pharma L.P. Regarding FDA’s Approval of Reformulated OxyContin® (oxycodone HCl controlled-release) Tablets

4/5/2010

Lee Woodruff Helps Shed Light on Chronic Pain, an Urgent Health Issue Facing Many Military Heroes & Their Families

3/31/2010

Purdue Pharma Provides Aid to Victims of Earthquake Disaster in Haiti

1/20/2010

Family Caregivers Can Overcome the Challenges of Chronic Pain

1/5/2010

2009

Purdue Pharma L.P. and the National Community Pharmacists Association Join Forces to Help Reduce Pharmacy Crime

10/22/2009

NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to support State Prescription Drug Monitoring Programs

10/21/2009

Richard Logan Receives 2009 NCPA Prescription Drug Safety Award

10/19/2009

Purdue Pharma L.P. Receives 2009 NCPA Corporate Recognition Award

10/19/2009

Statement of Purdue Pharma L.P. Regarding Joint Meeting of the U.S. Food and Drug Administration’s (FDA) Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

9/24/2009

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo® in the United States

8/3/2009

Purdue Pharma L.P. Presents Phase 3 Study of Transdermal Delivery of Buprenorphine in Moderate to Severe Pain

5/8/2009

New Once-Daily RYZOLT™ (tramadol HCl extended-release tablets) Now Available in the U.S.

5/7/2009

2008

PURDUE PHARMA L.P. ANNOUNCES A GLOBAL STRATEGIC ALLIANCE WITH INFINITY PHARMACEUTICALS TO ADVANCE DISCOVERY AND DEVELOPMENT PROGRAMS IN ONCOLOGY AND NEUROPATHIC PAIN

11/20/2008

Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Mallinckrodt Inc.

9/2/2008

Online Tool Helps Pain Advocacy Community Address Growing Public Health Crisis

7/24/2008

Purdue Pharma L.P. Supports Enhanced PhRMA Code on Interactions with Healthcare Professionals

7/15/2008

Statement of Purdue Pharma Regarding Joint Meeting of the U.S. Food and Drug Administration’s (FDA) Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

5/5/2008

Federal Court Affirms Enforceability of OxyContin Patents; Purdue Pharma Did Not Commit Inequitable Conduct, Court Concludes

1/7/2008

close  x

Email to a Friend or Colleague

Thank you! The page has been sent.

There was a problem sending this page, please try again.

Enter your email address and your friend’s email address,
then click the Send button.

*Indicates a required field

Sender’s email:*

Recipient’s email:*

Message: (max 500 characters)


No personal information including e-mail addresses about you or the recipient will be collected from this email notification feature offered by Purdue Pharma, L.P.

close  x